ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,842.91
0.11%
Dow Jones
42,518.28
0.52%
US Dollar vs MXN
20.5492
0.16%
Brent Oil
79.60
-0.13%
Bitcoin
97,330.00
0.86%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. GH Research PLC (GHRS) Cotización

GH Research PLC

GH Research PLC (GHRS)

NASDAQ
8.19
0.00
(0.00%)
Cerrado 15 Enero 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
Fuera de horario: -
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
8.19
Postura de Compra
5.49
Postura de Venta
9.06
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
5.50 Rango de 52 semanas 14.99
Capitalización de Mercado [m]
426.111M
Precio Anterior
8.19
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
74,743
Acciones en circulación
52,028,145
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-11.97
Beneficio por acción (BPA)
-0.68
turnover
-
Beneficio neto
-35.59M

Acerca de GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.ghres.com
Sede
Dublin, Irl
Fundado
-
GH Research PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GHRS. The last closing price for GH Research was US$8.19. Over the last year, GH Research shares have traded in a share price range of US$ 5.50 to US$ 14.99.

GH Research currently has 52,028,145 shares in issue. The market capitalisation of GH Research is US$426.11 million. GH Research has a price to earnings ratio (PE ratio) of -11.97.

GHRS Últimas noticias

Más noticias

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

10 Enero 2025
Edgar (US Regulatory)

GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents

Primary endpoint met in phase 2a POC trial in postpartum depression with a MADRS reduction from baseline of –35.4 points (p<0.0001, n=10) and 100% of patients in remission at Day 8Primary...

10 Enero 2025
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

05 Diciembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Noviembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

14 Noviembre 2024
Edgar (US Regulatory)

GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 clinical trial to evaluate proprietary aerosol...

14 Noviembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

20 Septiembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

16 Septiembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

09 Septiembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

03 Septiembre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.81-9998.021978078.49101895CS
4-0.01-0.1219512195128.210.236.72991058.05276508CS
12-0.1-1.206272617618.2911.096.72747438.43531429CS
26-3.71-31.176470588211.9146566238.62540346CS
522.2838.5786802035.9114.995.5747539.41344212CS
156-10.61-56.436170212818.821.325.057365910.53289436CS
260-13.81-62.77272727272230.435.058142113.28577593CS

GHRS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de GH Research?
El precio actual de las acciones de GH Research es US$ 8.19
¿Cuántas acciones de GH Research están en circulación?
GH Research tiene 52,028,145 acciones en circulación
¿Cuál es la capitalización de mercado de GH Research?
La capitalización de mercado de GH Research es USD 426.11M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de GH Research?
GH Research ha negociado en un rango de US$ 5.50 a US$ 14.99 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de GH Research?
El ratio precio/beneficio de GH Research es -11.97
¿Cuál es la moneda de reporte de GH Research?
GH Research presenta sus resultados financieros en GBP
¿Cuál es el último beneficio anual de GH Research?
El último beneficio anual de GH Research es GBP -35.59M
¿Cuál es la dirección registrada de GH Research?
La dirección registrada de GH Research es 28 BAGGOT STREET LOWER, DUBLIN 2, DUBLIN, D02 NX43
¿Cuál es la dirección del sitio web de GH Research?
La dirección del sitio web de GH Research es www.ghres.com
¿En qué sector industrial opera GH Research?
GH Research opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AALAmerican Airlines Group Inc
US$ 18.21
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1249
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.995
(0.00%)
0
AACGATA Creativity Global
US$ 0.91995
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 18.21
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1249
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.995
(0.00%)
0
AACGATA Creativity Global
US$ 0.91995
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 18.21
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1249
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.995
(0.00%)
0
AACGATA Creativity Global
US$ 0.91995
(0.00%)
0

Discusión

Ver feed completo
threewheeler threewheeler 2 minutos hace
01/15/2025 Expert Market IconCRTG The Coretec Group Inc. OTCQB Expert Market Common Stock
CRTG
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 3 minutos hace
People who bought the december offering at $3 a share sure are tasting some pain. Surprise the underwriters arent supporting the stock better.
IBRX
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 4 minutos hace
ImmunityBio has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of its common stock at the public offering price
I wonder if the underwriters exercised this option or not. $3 share price doesnt look to great a deal at the moment.
IBRX
martyDg martyDg 9 minutos hace
Does the big red in your nwbo position tell you it's derisked? LOL 
NWBO
GrantHorvat1 GrantHorvat1 11 minutos hace
It sure is...

If anyone wants to know what a totally clean, debt free shell looks like check out GVSI's latest annual...2024's will be filed imminently as well...the 8th of 2 years of Q's...we all know what that means and when it does it will set in motion a chain of events that will
GVSI
martyDg martyDg 13 minutos hace
Because LP is the perfect CEO of this company! She planned everything seamlessly. Per cult followers.
NWBO
GrantHorvat1 GrantHorvat1 14 minutos hace
Interesting that FUTS was touted as a clean shell...it is far from it. Veryyyyy interesting. Could work to our advantage however.

If anyone wants to know what a totally clean, debt free shell looks like check out G*VSI's latest annual...2024's will be filed imminently as well...the 8t
FUTS
Daytime_Lantern Daytime_Lantern 14 minutos hace
Hmm! Please elucidate regarding your statement ... "now I see something coming to shareholders that is really EXCITING!!"

GLTA!
BIEL
Babubd Babubd 24 minutos hace
https://www.otcmarkets.com/otcapi/company/dns/news/document/79610/content
TRII
GrantHorvat1 GrantHorvat1 24 minutos hace
Looks like around 233k in debt to 3 noteholders issued around 5 years ago. Obviously more at this point with accrued interest owed. Still outstanding as far as I can tell.

So to the people who said this was a clean shell and debt free....wrong as usual 🙄.

But th
FUTS
mick mick 24 minutos hace
thank you
MasterBlastr MasterBlastr 31 minutos hace
Schauffele withdraws from The American Express for medical reasons

https://apnews.com/article/xander-schauffele-american-express-pga-tour-d2d984c7409ac312969147f9525d5f2a
aBeezlee aBeezlee 31 minutos hace
This is a highly speculative field. Rigetti may not match top companies in benchmarks, but that doesn't mean they can't cut out their own piece of the pie. I have no idea when they'll be profitable or show significant revenue, but we can't pretend to know the future.

I'm going to kee
RGTI
SkeBallLarry SkeBallLarry 33 minutos hace
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

((( They are gettin' nervous ))) ... !!!
hyder hyder 34 minutos hace
Thanks and IMO you made a very wise investment decision. I am confident we will be wealthy soon. Go $$$$$NWBO$$$$$ 
NWBO
SkeBallLarry SkeBallLarry 34 minutos hace
" Thanks 'n Good Morning, CrudeOil " .. !!
mick mick 36 minutos hace
is scheffele wd
SkeBallLarry SkeBallLarry 36 minutos hace
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

((( They are gettin' nervous ))) ... !!!
SkeBallLarry SkeBallLarry 38 minutos hace
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

((( They are gettin' nervous, Bull ))) ... !!!
SkeBallLarry SkeBallLarry 39 minutos hace
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 40 minutos hace
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
eagle8 eagle8 40 minutos hace
Sorry to hear that XMaster.

All the best.
NWBO
Seminole Red Seminole Red 46 minutos hace
I wonder if it would be interesting to see the biggest Loosing stock of the day also ? sort of like a warning to whoever has it .
jeunke22 jeunke22 50 minutos hace
Lesson for all here. Reason I am long and positive like so many others here. Investing in Lightwave, a pre revenue company, is a question of belief, risk tolerance and the financial ability to persevere. It’s even more risky than investing in a revenue generating company like NVIDIA in 2018 as thi
LWLG
amelia43 amelia43 54 minutos hace
Shorting now is a very bad move.

To be fair, any hint of bad news will drop these down to the basement too.

Still shorting is not the move!
FNMA

Su Consulta Reciente

NASDAQ
GHRS
GH Research
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados